| Today's Open | $36.46 |
|---|---|
| Previous Close | $36.59 |
| Daily Range | $36.15 - $36.60 |
| 52-Week Range | $28.62 - $37.78 |
| Market Cap | $6.1B |
| P/E Ratio | -84.70 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 360,976 |
| Average Daily Volume | 1,064,468 |
| Current FY EPS | $2.02 |
Sector
Healthcare
Industry
Drugs
Hospira, Inc. (HSP) Description
A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care. Website: http://www.hospira.com/
News & Commentary
This Blockbuster Biologic May Face a Steep Cliff
Neulasta generated sales north of $4 billion for Amgen in 2012, but generic competition is brewing on two continents.UPDATE: Hospira Data on European Biosimilar Epoetin, Retacrit Affirm Treatment Response, Says Study
UPDATE: Hospira Data on European Biosimilar Epoetin, Retacrit Affirm Treatment Response, Says Study Met Primary EndpointHSP's Top Competitors
(0.00%)
(0.00%)
(0.00%)